Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc. Share Price Today (NASDAQ: ICPT)

Intercept Pharmaceuticals, Inc. share price is $0 & ₹0.00 as on 6 Nov 2023 IST

▲

-19

(-100%)

Market is closed - opens 7 PM, 30 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 7 Nov 2023

View live Intercept Pharmaceuticals, Inc. share price in Dollar and Rupees. Guide to invest in Intercept Pharmaceuticals, Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Intercept Pharmaceuticals, Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Intercept Pharmaceuticals, Inc. (ICPT) Key Statistics

in dollars & INR

Previous Close
$19.0
Open
$19.0
Market Capitalization
$793.5M
Today's Volume
$4.0M
Revenue TTM
$306.5M
EBITDA
$-66.5M
Earnings Per Share (EPS)
$-4.26
Dividend Yield
0.0%
Profit Margin
68.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Intercept Pharmaceuticals, Inc. Stock (ICPT) from India?

It is very easy for Indian residents to invest directly in Intercept Pharmaceuticals, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Intercept Pharmaceuticals, Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Intercept Pharmaceuticals, Inc. or ICPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Intercept Pharmaceuticals, Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Intercept Pharmaceuticals, Inc. shares which would translate to null fractional shares of Intercept Pharmaceuticals, Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Intercept Pharmaceuticals, Inc., in just a few clicks!

Global Institutional Holdings in Intercept Pharmaceuticals, Inc.

  • Vanguard Group Inc

    11.23%

  • BlackRock Inc

    10.52%

  • State Street Corporation

    10.00%

  • Deerfield Management Co

    4.97%

  • UBS Group AG

    3.25%

  • Caligan Partners LP

    3.09%

Analyst Recommendation on Intercept Pharmaceuticals, Inc.

Rating
Trend

Hold

    35%Buy

    65%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Intercept Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis and NASH; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New Jersey.
Organization
Intercept Pharmaceuticals, Inc.
Employees
341
CEO
Mr. Jerome B. Durso
Industry
Health Technology

Important FAQs about investing in ICPT Stock from India :

Can Indians buy Intercept Pharmaceuticals, Inc. shares?

Yes, Indians can invest in the Intercept Pharmaceuticals, Inc. (ICPT) from India.

With INDmoney, you can buy Intercept Pharmaceuticals, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Intercept Pharmaceuticals, Inc. at zero transaction cost.

How can I buy Intercept Pharmaceuticals, Inc. shares from India?

It is very easy to buy Intercept Pharmaceuticals, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Intercept Pharmaceuticals, Inc. (ICPT) be purchased?

Yes, you can buy fractional shares of Intercept Pharmaceuticals, Inc. with INDmoney app.

What are the documents required to start investing in Intercept Pharmaceuticals, Inc. stocks?

To start investing in Intercept Pharmaceuticals, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Intercept Pharmaceuticals, Inc.?

Today's market capitalisation of Intercept Pharmaceuticals, Inc. ICPT is 793.5M

Who is the Chief Executive Officer (CEO) of Intercept Pharmaceuticals, Inc. ?

Mr. Jerome B. Durso is the current Chief Executive Officer (CEO) of Intercept Pharmaceuticals, Inc..